Takeda, Generics Push To Toss Actos Buyers' Antitrust Suit
Takeda and four generic-drug manufacturers told a New York federal court Friday to dismiss antitrust claims brought by a proposed class that bought diabetes drug Actos, saying that the purchasers' most...To view the full article, register now.
Already a subscriber? Click here to view full article